Cell & Gene Therapy Research Services
Accelerating the Development of Next-Generation Cell & Gene Therapies
Cell and Gene Therapy (CGT) is transforming the future of medicine. From personalized cancer treatments to therapies for genetic and rare diseases, these innovative approaches offer the potential to address conditions that were once considered difficult or impossible to treat.
However, developing successful cell and gene therapies requires overcoming complex scientific challenges. Efficient gene delivery, vector optimization, immune response evaluation, potency assessment, and reproducible functional testing are all critical to therapeutic success.
At ImmunitasBio, we provide advanced Cell & Gene Therapy Research Services that help biotechnology companies, pharmaceutical innovators, and research organizations generate the critical preclinical data needed to accelerate development and reduce risk.
Whether you are developing CAR-T therapies, gene-modified cell products, viral vectors, mRNA delivery systems, lipid nanoparticles (LNPs), or next-generation gene therapies, our scientific team provides the expertise and analytical support needed to move programs forward with confidence.
Why Are Cell & Gene Therapy Research Services Important?
The success of a cell or gene therapy depends on more than just innovative science.
Developers must answer important questions such as:
Our Preclinical Cell & Gene Therapy Services are designed to answer these questions through robust biological testing, immune profiling, and functional evaluation.
A Complete Cell & Gene Therapy Development Platform
ImmunitasBio provides an integrated portfolio of Gene Therapy Research Services and Cell Therapy Development Services, helping organizations streamline research through a single scientific partner.
Our expertise includes:
By combining these capabilities, we help sponsors generate decision-ready data that supports therapeutic optimization and successful development strategies.
Lentiviral Vector Development Services
Efficient gene delivery begins with a well-designed vector.
Our Lentiviral Vector Development Services support preclinical gene therapy programs through:
Our team helps optimize vector performance while ensuring high-quality data generation throughout development.
CAR-T Cell Development and Functional Assessment
CAR-T therapies continue to redefine cancer treatment by enabling immune cells to specifically recognize and eliminate tumor cells.
Our CAR-T Cell Development Services support:
We generate comprehensive datasets that help developers understand therapeutic performance and optimize CAR designs.
Functional Immune Profiling and Tumor Cell Killing Assays
Understanding immune behavior is essential for successful cell therapy development.
Our immune profiling platform evaluates:
These insights help determine whether engineered cells can deliver durable therapeutic responses.
Lipid Nanoparticle (LNP) Characterization Services
Lipid Nanoparticles play a critical role in modern gene delivery technologies, including mRNA therapeutics and nucleic acid-based medicines.
Our LNP Characterization Services provide:
These studies help developers optimize delivery systems and improve therapeutic performance.
Immune Assays, Biomarker Profiling & Expression Analysis
The immune response often determines the success or failure of a cell or gene therapy.
Our Immune Assays and Biomarker Profiling Services include:
These capabilities help sponsors identify biomarkers, monitor therapeutic responses, and strengthen translational development strategies.
Custom Bioassays & Potency Testing Services
Every therapy is unique.
Our Custom Bioassay Development Services are designed to generate relevant biological data specific to your product.
Capabilities include:
Why Partner with ImmunitasBio?
As a trusted partner for Cell & Gene Therapy Research Services in India, we combine scientific expertise, advanced analytical capabilities, and collaborative project execution to support innovative therapeutic programs.
Our advantages include:
We help innovators generate the critical data needed to accelerate therapeutic development and bring transformative treatments closer to patients.
